期刊
EXPERT REVIEW OF ANTICANCER THERAPY
卷 6, 期 12, 页码 1769-1785出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737140.6.12.1769
关键词
anergy; antigen; chemokine; cytokine; dendritic cell; immunotherapy; multiple myeloma; T cell; vaccine
类别
The field of tumor immunotherapy is still in its infancy. It is becoming clear that the human immune response is the result of highly complex, continuously evolving interactions between cells of the adaptive and innate arms of the immune system, the internal and external environments, and normal and abnormal cells (e.g., myeloma plasma cells). Despite the considerable advances in our knowledge over the past 30 years, we have still only scratched the surface of the immune system's interaction with malignant diseases such as myeloma and to date, this has not translated into significantly better outcomes for patients with this disease. This review will summarize our current knowledge of the fundamental immunology of myeloma, review immunotherapy trials reported to date and discuss whether, in light of the current information, immunotherapy of multiple myeloma is an achievable goal.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据